BISOCE 3.75 mg, film-coated tablet scored 30 tablets
Active ingredients: Bisoprolol monofumarate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BISOCE 3,75 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 30 comprimé(s)
- Marketing authorisation holder
- MYLAN SAS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 2 Dec 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61897671CIP73531442CIP133400935314420Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HÉMIFUMARATE DE BISOPROLOLcomprimé | 3,75 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.